The Bull Market Isn't Sick Anymore

The speaker says the S&P 500 is currently the most buyable equity index and reports being long SPY and RSP. Of 48 S&P 500 companies reporting so far, 43 beat expectations, with an average surprise of 3.4%, below Q2’s average; the speaker cautions that the comparison is not yet very meaningful.

Analysis

The early beat rate is a weak signal on its own: reported beats can reflect a low comparison bar, and the small sample may be skewed by which companies report first. The market-relevant test is whether results translate into upward forward-estimate revisions and resilient margins as reporting broadens. For SPY, index concentration can sustain returns even if the median constituent is less healthy; RSP is a cleaner, though imperfect, test of whether strength is spreading beyond the largest weights. That makes owning both a bet on aggregate earnings and on breadth, not simply a diversified version of one view. In the next few weeks, guidance and estimate revisions matter more than the raw beat count. Over 1–3 months, watch RSP relative to SPY and the direction of forward EPS revisions; persistent breadth and revisions would support the equal-weight exposure. Over 6–18 months, the thesis depends on earnings growth holding up against financing costs and labor/input pressures. The contrarian risk is that investors treat routine beats as confirmation before the guidance and revision data do. Conversely, if broad revisions improve while RSP has lagged, breadth exposure may be underappreciated. No valuation, positioning, or estimate-revision data are supplied, so this is not enough to justify adding risk aggressively.

Key Decisions for Investors

• Do not add to SPY and RSP solely on the reported beat ratio. Keep any existing index exposure within risk limits and reassess as a larger, more representative portion of the index reports.
• Treat RSP versus SPY as the breadth monitor: consider adding relative RSP exposure only if it begins to outperform alongside improving forward EPS revisions; if revisions improve only among the largest index weights, favor SPY over RSP.
• Over the next 1–3 months, track forward estimate revisions, company guidance, and margin commentary—not just reported EPS versus estimates. A broad turn to downward revisions or weakening margin guidance would falsify the earnings-breadth thesis.
• Before increasing exposure, verify the reporting sample’s sector and market-cap mix and whether beats were driven by revenue growth or cost reductions; absent that detail, the signal remains insufficient for a directional trade.